Begin main content

Reports

We found 5860 result(s)

icosapent ethyl (Vascepa)

Last Updated: January 17, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New

caplacizumab (Cablivi)

Last Updated: January 14, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Active
  • Submission Type: New

vedolizumab (Entyvio )

Last Updated: January 16, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vedolizumab
Indications: Ulcerative Colitis

  • Brand Name: Entyvio
  • Manufacturer: Takeda Canada Inc.
  • Project Number: SR0635-000
  • Project Status: Active
  • Submission Type: New

upadacitinib (Rinvoq)

Last Updated: January 16, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: upadacitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: Rinvoq
  • Manufacturer: AbbVie
  • Project Number: SR0614-000
  • Project Status: Active
  • Submission Type: New

sodium zirconium cyclosilicate (Lokelma)

Last Updated: January 7, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: sodium zirconium cyclosilicate
Indications: Hyperkalemia, adults

  • Brand Name: Lokelma
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0612-000
  • Project Status: Active
  • Submission Type: New

safinamide (Onstryv)

Last Updated: January 10, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New

burosumab (Crysvita)

Last Updated: November 28, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Active
  • Submission Type: New

erenumab (Aimovig)

Last Updated: January 15, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New

Early Identification of Stroke

Last Updated: January 17, 2020
Result type: Reports

Every year in Canada, there are more than 50,000 new strokes and 14,000 deaths from stroke. The first step to delivering optimal stroke care is fast and effective management in the pre-hospital environment. There are numerous opportunities for time saving in pre-hospital stroke care — from detection to triage to transportation. This Horizon Scan...

  • Project Number: EH0080-000